Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects (Q37150064)
Jump to navigation
Jump to search
scientific article published on 29 April 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects |
scientific article published on 29 April 2008 |
Statements
1 reference
Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects (English)
1 reference
Heather-Jane Au
1 reference
Kamran Golmohammadi
1 reference
Tallal Younis
1 reference
Shailendra Verma
1 reference
Stephen Chia
1 reference
Konrad Fassbender
1 reference
Philip Jacobs
1 reference
29 April 2008
1 reference
1 reference
114
1 reference
3
1 reference
579-587
1 reference
Identifiers
1 reference
1 reference